Case Study: a US-based cancer diagnostics company achieves 100% automation and $1.34M cost savings with Elucidata's Polly

US-based Cancer Diagnostics Company achieves 100% automation and saves ~$1.34M with Elucidata

A US-based cancer diagnostics company sought to leverage its proprietary single-cell multiome data to identify diagnostic markers for AML. However, it faced major challenges including a lack of templatized solutions for data ingestion and processing, the large size of datasets, and insufficient infrastructure. They partnered with Elucidata to streamline their data management workflow from ingestion to insight generation.

Elucidata implemented a well-rounded solution featuring customized pipelines, a robust and scalable compute infrastructure, and a tailor-made web app to support the workflow end-to-end. This partnership provided the customer with 100% automation and seamless scalability for their single-cell data operations, resulting in significant cost savings of approximately $1.34 million.